The JANUS serum bank
- PMID: 8272856
- DOI: 10.1016/0048-9697(93)90049-c
The JANUS serum bank
Abstract
The on-going JANUS project was initiated by the Norwegian Cancer Society in 1973. The serum bank comprises close to 0.5 million serum samples collected from 170,000 donors. From 2-16 consecutive samples are available from each donor. The sera are stored at -25 degrees C. At regular intervals the JANUS-collection is matched against the files of the Norwegian Cancer Registry. From 1973 to 1991 almost 5000 of the donors have developed some form of cancer. Frozen serum samples collected from a few months to 18 years prior to clinical recognition of their disease are consequently available for research purposes. The aim of the JANUS-project is to search in these premorbid sera for chemical, biochemical, immunological or other changes that might be indicative of cancer development at early stages. Gas chromatography-mass spectrometry and two-dimensional protein electrophoresis have been used to evaluate the stability of the frozen sera. Some recent findings are: CA125 is elevated several months prior to diagnosis of ovarian cancer; serum thyroglobulin may be a preclinical tumour marker in subgroups of thyroid cancer; low level of selenium in serum reflects increased risk of thyroid cancer; and raised antibodies in serum against Epstein-Barr virus is a risk factor for development of Hodgkin's disease. On-going research includes trace elements and cancer, and studies on lipid-profiles, diet and cancer. The serum bank may in principle be used for other purposes, e.g. in environmental studies. Analysis of sequential sera may determine chemical substances in the sera that might reflect differences in exposure to environmental pollutants in the period 1973-1991.
Similar articles
-
Experiences of the Janus Serum Bank in Norway.Environ Health Perspect. 1995 Apr;103 Suppl 3(Suppl 3):85-8. doi: 10.1289/ehp.95103s385. Environ Health Perspect. 1995. PMID: 7635118 Free PMC article.
-
Cohort Profile Update: The Janus Serum Bank Cohort in Norway.Int J Epidemiol. 2017 Aug 1;46(4):1101-1102f. doi: 10.1093/ije/dyw302. Int J Epidemiol. 2017. PMID: 28087783 No abstract available.
-
Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer.Br J Cancer. 1988 Jan;57(1):105-8. doi: 10.1038/bjc.1988.19. Br J Cancer. 1988. PMID: 3348941 Free PMC article.
-
Advanced ovarian cancer. Tumour markers.Ann Oncol. 1993;4 Suppl 4:71-7. Ann Oncol. 1993. PMID: 8312203 Review.
-
The past is prologue: use of serum banks in cancer research.Cancer Res. 1992 Oct 1;52(19 Suppl):5557s-5560s. Cancer Res. 1992. PMID: 1394173 Review.
Cited by
-
Experiences of the Janus Serum Bank in Norway.Environ Health Perspect. 1995 Apr;103 Suppl 3(Suppl 3):85-8. doi: 10.1289/ehp.95103s385. Environ Health Perspect. 1995. PMID: 7635118 Free PMC article.
-
Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.Br J Cancer. 2010 May 25;102(11):1665-9. doi: 10.1038/sj.bjc.6605675. Epub 2010 Apr 20. Br J Cancer. 2010. PMID: 20407437 Free PMC article.
-
Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis.RNA Biol. 2020 Oct;17(10):1416-1426. doi: 10.1080/15476286.2020.1771945. Epub 2020 Jun 16. RNA Biol. 2020. PMID: 32456538 Free PMC article.
-
Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.PLoS One. 2015 Sep 9;10(9):e0137503. doi: 10.1371/journal.pone.0137503. eCollection 2015. PLoS One. 2015. PMID: 26352148 Free PMC article.
-
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.J Clin Oncol. 2015 Jun 20;33(18):2041-50. doi: 10.1200/JCO.2014.59.1602. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964249 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous